Annual EBITDA:
$19.23M+$461.98M(+104.34%)Summary
- As of today, BPMC annual EBITDA is $19.23 million, with the most recent change of +$461.98 million (+104.34%) on December 31, 2024.
- During the last 3 years, BPMC annual EBITDA has risen by +$646.93 million (+103.06%).
Performance
BPMC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly EBITDA:
$23.55M+$50.66M(+186.85%)Summary
- As of today, BPMC quarterly EBITDA is $23.55 million, with the most recent change of +$50.66 million (+186.85%) on March 31, 2025.
- Over the past year, BPMC quarterly EBITDA has dropped by -$85.65 million (-78.43%).
Performance
BPMC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM EBITDA:
-$66.41M-$85.65M(-445.28%)Summary
- As of today, BPMC TTM EBITDA is -$66.41 million, with the most recent change of -$85.65 million (-445.28%) on March 31, 2025.
- Over the past year, BPMC TTM EBITDA has increased by +$153.50 million (+69.80%).
Performance
BPMC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BPMC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +104.3% | -78.4% | +69.8% |
| 3Y3 Years | +103.1% | +123.3% | +89.5% |
| 5Y5 Years | +105.4% | +121.0% | -120.0% |
BPMC EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +103.1% | -78.4% | +117.0% | -445.3% | +90.3% |
| 5Y | 5-Year | -93.9% | +103.1% | -96.3% | +107.6% | -119.2% | +90.3% |
| All-Time | All-Time | -93.9% | +103.1% | -96.3% | +107.6% | -119.2% | +90.3% |
BPMC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $23.55M(+186.9%) | -$66.41M(-445.3%) |
| Dec 2024 | $19.23M(+104.3%) | -$27.11M(+18.8%) | $19.23M(+140.1%) |
| Sep 2024 | - | -$33.37M(-13.2%) | -$47.97M(+63.7%) |
| Jun 2024 | - | -$29.48M(-127.0%) | -$132.10M(+39.9%) |
| Mar 2024 | - | $109.20M(+215.8%) | -$219.91M(+50.3%) |
| Dec 2023 | -$442.75M(+14.3%) | -$94.32M(+19.7%) | -$442.75M(+9.0%) |
| Sep 2023 | - | -$117.51M(-0.2%) | -$486.66M(+0.4%) |
| Jun 2023 | - | -$117.28M(-3.2%) | -$488.46M(+7.2%) |
| Mar 2023 | - | -$113.64M(+17.8%) | -$526.28M(-2.5%) |
| Dec 2022 | -$516.84M(+17.7%) | -$138.23M(-15.9%) | -$513.56M(+25.1%) |
| Sep 2022 | - | -$119.31M(+23.1%) | -$685.26M(-1.0%) |
| Jun 2022 | - | -$155.10M(-53.7%) | -$678.17M(-7.6%) |
| Mar 2022 | - | -$100.91M(+67.4%) | -$629.98M(-0.4%) |
| Dec 2021 | -$627.70M(-299.1%) | -$309.94M(-176.2%) | -$627.70M(-56.1%) |
| Sep 2021 | - | -$112.21M(-4.9%) | -$402.05M(-216.5%) |
| Jun 2021 | - | -$106.92M(-8.4%) | $345.17M(+5.0%) |
| Mar 2021 | - | -$98.63M(-17.0%) | $328.72M(+4.3%) |
| Dec 2020 | $315.27M(+188.5%) | -$84.29M(-113.3%) | $315.26M(-5.0%) |
| Sep 2020 | - | $635.01M(+614.7%) | $331.75M(+183.0%) |
| Jun 2020 | - | -$123.37M(-10.1%) | -$399.93M(-5.4%) |
| Mar 2020 | - | -$112.09M(-65.3%) | -$379.26M(-6.5%) |
| Dec 2019 | -$356.07M | -$67.80M(+29.9%) | -$356.07M(+5.8%) |
| Sep 2019 | - | -$96.67M(+5.9%) | -$377.87M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$102.70M(-15.5%) | -$352.75M(-27.8%) |
| Mar 2019 | - | -$88.89M(+0.8%) | -$275.94M(-13.7%) |
| Dec 2018 | -$242.78M(-62.2%) | -$89.61M(-25.2%) | -$242.78M(-18.4%) |
| Sep 2018 | - | -$71.55M(-176.3%) | -$205.12M(-20.1%) |
| Jun 2018 | - | -$25.89M(+53.5%) | -$170.83M(+4.0%) |
| Mar 2018 | - | -$55.74M(-7.3%) | -$177.90M(-18.9%) |
| Dec 2017 | -$149.67M(-112.5%) | -$51.94M(-39.4%) | -$149.67M(-26.3%) |
| Sep 2017 | - | -$37.26M(-13.0%) | -$118.51M(-21.5%) |
| Jun 2017 | - | -$32.96M(-19.8%) | -$97.56M(-17.6%) |
| Mar 2017 | - | -$27.51M(-32.4%) | -$82.97M(-17.8%) |
| Dec 2016 | -$70.44M(-37.8%) | -$20.78M(-27.3%) | -$70.44M(-8.8%) |
| Sep 2016 | - | -$16.32M(+11.2%) | -$64.75M(-6.7%) |
| Jun 2016 | - | -$18.37M(-22.6%) | -$60.70M(-10.5%) |
| Mar 2016 | - | -$14.98M(+0.7%) | -$54.92M(-7.4%) |
| Dec 2015 | -$51.13M(-30.4%) | -$15.08M(-22.9%) | -$51.13M(-1.9%) |
| Sep 2015 | - | -$12.27M(+2.6%) | -$50.16M(-4.2%) |
| Jun 2015 | - | -$12.60M(-12.7%) | -$48.13M(-10.4%) |
| Mar 2015 | - | -$11.18M(+20.8%) | -$43.59M(-11.2%) |
| Dec 2014 | -$39.21M(-93.4%) | -$14.11M(-37.8%) | -$39.21M(-56.2%) |
| Sep 2014 | - | -$10.24M(-27.1%) | -$25.10M(-68.9%) |
| Jun 2014 | - | -$8.06M(-18.5%) | -$14.86M(-118.5%) |
| Mar 2014 | - | -$6.80M | -$6.80M |
| Dec 2013 | -$20.27M | - | - |
FAQ
- What is Blueprint Medicines Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation annual EBITDA year-on-year change?
- What is Blueprint Medicines Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation quarterly EBITDA year-on-year change?
- What is Blueprint Medicines Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation TTM EBITDA year-on-year change?
What is Blueprint Medicines Corporation annual EBITDA?
The current annual EBITDA of BPMC is $19.23M
What is the all-time high annual EBITDA for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high annual EBITDA is $315.27M
What is Blueprint Medicines Corporation annual EBITDA year-on-year change?
Over the past year, BPMC annual EBITDA has changed by +$461.98M (+104.34%)
What is Blueprint Medicines Corporation quarterly EBITDA?
The current quarterly EBITDA of BPMC is $23.55M
What is the all-time high quarterly EBITDA for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high quarterly EBITDA is $635.01M
What is Blueprint Medicines Corporation quarterly EBITDA year-on-year change?
Over the past year, BPMC quarterly EBITDA has changed by -$85.65M (-78.43%)
What is Blueprint Medicines Corporation TTM EBITDA?
The current TTM EBITDA of BPMC is -$66.41M
What is the all-time high TTM EBITDA for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high TTM EBITDA is $345.17M
What is Blueprint Medicines Corporation TTM EBITDA year-on-year change?
Over the past year, BPMC TTM EBITDA has changed by +$153.50M (+69.80%)